Suppr超能文献

迟发型超敏反应中的炎性小体激活

Inflammasome activation in delayed-type hypersensitivity reactions.

作者信息

Yazdi Amir S, Ghoreschi Kamran, Röcken Martin

机构信息

Department of Dermatology, University of Tübingen, Tübingen, Germany.

出版信息

J Invest Dermatol. 2007 Aug;127(8):1853-5. doi: 10.1038/sj.jid.5700815.

Abstract

The inflammasome is a protein complex cleaving the pro-inflammatory cytokines IL-1beta and IL-18 into their active forms by caspase-1 activation. The cytosolic protein complex can be activated by danger signals, such as bacterial and viral components, ATP, or uric acid crystals, and reacts as a sensor of innate immunity. In the skin, sensitizing agents promote induction of specific T-cell-mediated contact hypersensitivity. They induce dendritic cell migration, a precondition for the priming of specific T cells. They are a prerequisite for the recruitment of cells into the skin that demand pro-inflammatory stimuli, such as IL-1beta and IL-18. Watanabe et al. (2007, this issue) demonstrate the presence of the inflammasome complex in keratinocytes and report that this complex can be activated by contact sensitizers, such as trinitrocholorobenzene (TNCB), both in vitro and in vivo. The study documents a regulatory effect of innate immunity in a T-cell-mediated delayed-type hypersensitivity reaction.

摘要

炎性小体是一种蛋白质复合物,通过激活半胱天冬酶-1将促炎细胞因子白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)切割成其活性形式。这种胞质蛋白复合物可被危险信号激活,如细菌和病毒成分、三磷酸腺苷(ATP)或尿酸晶体,并作为固有免疫的一种传感器发挥作用。在皮肤中,致敏剂可促进特异性T细胞介导的接触性超敏反应的诱导。它们诱导树突状细胞迁移,这是启动特异性T细胞的一个先决条件。它们是将需要促炎刺激(如IL-1β和IL-18)的细胞募集到皮肤中的一个先决条件。渡边等人(2007年,本期)证明角质形成细胞中存在炎性小体复合物,并报告该复合物在体外和体内均可被接触性致敏剂(如三硝基氯苯[TNCB])激活。该研究证明了固有免疫在T细胞介导的迟发型超敏反应中的调节作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验